FDA Approves New BARDA-Supported
Smallpox Antiviral Drug
The FDA’s approval of TPOXX® (tecovirimat) — the first and only approved antiviral treatment for smallpox — marks a milestone for biosecurity and a triumph against one of the most deadly diseases in history. The approval also serves as an exemplary model of government working collaboratively with its interagency partners and industry to meet a national biodefense need.
Un informe de la OMM prevé que el fenómeno se fortalezca hasta alcanzar una intensidad elevada y persista hasta entrado 2027. Expertos advierten que...
